Stocks
Zenas BioPharma, Inc.ZBIO
NASDAQHealthcareBiotechnology$24.63
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing novel therapies for autoimmune and inflammatory diseases, with a lead candidate targeting neonatal Fc receptor (FcRn) pathways. Its pipeline includes programs for immune thrombocytopenia and other IgG-mediated disorders, and investors track it for its differentiated approach to FcRn inhibition and upcoming clinical data readouts.
52W Range: $13.50-$44.60
Congressional Interest in Zenas BioPharma, Inc. (ZBIO)
No congressional trades have been disclosed for Zenas BioPharma, Inc. (ZBIO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ZBIO?
No congressional trades found for this stock.